Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06048536 Completed - Contraception Clinical Trials

Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch

Start date: December 22, 2023
Phase: Phase 2
Study type: Interventional

A single-center, randomized, open-label, parallel-group, multi-arm, phase II clinical trial in healthy women aged 18 to 35 years who have a documented ovulatory cycle prior to randomization.

NCT ID: NCT06042556 Completed - Contraception Clinical Trials

IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings

Start date: April 3, 2021
Phase: N/A
Study type: Interventional

Investigators previously developed a guide to help people with IUD self-removal. In this randomized study, the goal is to see if this guide makes it easier for IUD-users to remove their own IUDs. The main question the study aims to answer is: -Does use of the previously developed IUD self-removal guide increase rates of self removal? Participants will: - Complete a pre-study survey - Be randomized to self-removal with use of the guide or no additional resource - Self-select participation at home or in clinic - Attempt IUD self-removal either at home or in clinic - Complete a post-study survey. Investigators will compare rates of successful self-removal between those randomized to the guide to those randomized to no additional resource to see if increases success.

NCT ID: NCT05800548 Completed - Contraception Clinical Trials

Health Literacy of Postpartum Women and Family Planing

Start date: March 1, 2022
Phase:
Study type: Observational

This study was carried out as a cross-sectional-relationship searcher in order to determine the effect of evaluating the relationship between health literacy and family planning attitudes of postpartum women. The population of the study consisted of puerperant women in the Postpartum Clinic of Osmaniye State Hospital between March 2022 and June 2022. The sample of the research is; puerperant women who applied to the hospital for delivery within the research dates and gave birth in a healthy way, did not have any risk for the mother and the baby, had no communication barriers and met the research criteria. The sample number of the study was calculated using the G*Power 3.1.9.4 program. The puerperant women who met the inclusion criteria were included in the study with the method of improbable random sampling, and a total of 258 puerperant women were reached. In data collection; Socio-demographic and obstetric characteristics of puerperant women, descriptive information form including questions about current birth, Postpartum Family Planning Attitude Scale The Health Literacy Scale was used. In the study, a very strong positive correlation was found between the women's total PAPTS score and SAS total score (p=0.000). In other words; As the health literacy levels of postpartum women increase, their family planning attitude levels also increase

NCT ID: NCT05763264 Completed - Contraception Clinical Trials

TITLE SAGCS2 Protocol 2.3 + Amend 1

Start date: October 12, 2020
Phase: N/A
Study type: Interventional

The clinical study will compare two lubricated polyurethane male condoms of different thickness with a marketed lubricated control male condom made of natural rubber latex. This crossover study will randomize 300 heterosexual couples to the sequence in which they use five condoms of each of the three study condom types. The clinical failure (breakage and slippage) rates of the two polyurethane condoms will be compared to the clinical failure (breakage and slippage) rate of commercial natural rubber latex control condom using a statistical test of non-inferiority. The study will also compare the acceptability of the two polyurethane condom different thickness with that of the natural rubber latex control condom obtained from interviews and questionnaires with subject couples.

NCT ID: NCT05725278 Completed - Contraception Clinical Trials

Impact Evaluation of Triggerise's Tiko Platform

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

Triggerise designed web and phone based Tiko platform to connect young girls and women to the health products, services and information. The platform uses principles of behaviour economics to motivate positive choices-including rewards, promotions, discounts, coupons, reminders, alerts etc. The platform was implemented in several cities from seven states of India to provide Sexual Reproductive Health (SRH) and maternal and child health (MCH) products and services. The consumers (called Rafikis) use Tiko card to get discounts and to earn 'Tiko miles' rewards at Tiko franchised healthcare providers and pharmacies. Tiko miles are redeemable towards lifestyle products or services (e.g., beauty salons). The local Tiko health promoter (celled Pro agent) can also buy health and hygiene products at bulk discounts and sell them at profit. Triggerise appointed Network for Engineering, Economics Research and Management (NEERMAN) to conduct an independent impact assessment of the Tiko platform with multiple research objectives include health impact evaluation at the Rafiki level. NEERMAN used an ex-post observational design to compare usage of SRH and MCH services and family planning (FP), antenatal care (ANC) and postnatal care (PNC) practices by comparing Users and Non-Users of Tiko platform, and accounting for the selection bias statistically. The structured questionnaire collected data on knowledge, practices, barriers, enablers for SRH and MCH services, exposure o Tiko platform, and how it helped or did not help. The survey participants were approx. 1200 users and 600 non-users being served by approx. 350 pro-agents in their respective operations area. The association between use of Tiko platform and various outcomes were identified using a generalized linear model with fixed effects at pro-agent level and including a set of covariates. To evaluate the effect modification by type of pro agent - government community health worker (CHW) versus others - an interaction model was used. The standard errors were automatically clustered at pro-agent level due to fixed effects. Primary outcomes are proportion of married Rafikis currently using any contraceptives, currently using modern short-term contraceptives, proportion of Rafikis who delivered a child post Jan 2019 and received at least 4 ANC check-ups, consumed at least 100 iron folic acid (IFA( during pregnancy, and received a PNC check-up within 6 weeks of birth.

NCT ID: NCT05677035 Completed - Contraception Clinical Trials

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects

Start date: January 11, 2022
Phase: Phase 1
Study type: Interventional

A single-center, open-label, parallel-group, phase 1 study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of LINO-1713 in healthy Korean female subjects

NCT ID: NCT05383924 Completed - Contraception Clinical Trials

Intrauterine Contraceptive Device Insertion During Cesarean Section (CS) Versus Delayed Insertion

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

After ethical committee approval and written consent from the patients, this prospective quasi-randomized controlled clinical trial was performed on pregnant women planning to deliver by cesarean section and willing to participate in the study to investigate the value of immediate post placental IUD insertion versus delayed insertion on patient's compliance in Ain Shams University Maternity Hospital (ASUMH).

NCT ID: NCT05309694 Completed - Contraception Clinical Trials

A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

Start date: March 4, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate that a new device inserter leads to successful and safe insertion of Paragard® IUS, comparable to the currently approved IUS inserter, in females of reproductive potential.

NCT ID: NCT05294341 Completed - Contraception Clinical Trials

Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate

Start date: July 22, 2022
Phase: Phase 4
Study type: Interventional

0.35mg norethindrone, also known as progesterone only pills, are routinely prescribed as immediate postpartum oral contraception. Norethindrone acetate is prescribed for gynecologic indications, but has never been studied as an efficacious form of contraception. This is a pilot crossover study examining the pharmacokinetics of norethindrone, the metabolically active component of both drugs, in participants taking 5mg norethindrone and 0.35mg norethindrone acetate.

NCT ID: NCT05263544 Completed - Contraception Clinical Trials

Uterine Anatomical Flexion Degree ( Uterocervical Angle) and Intrauterine Device (IUD) Dislocation

Start date: June 30, 2021
Phase:
Study type: Observational

Investigators want to find numerical determination of the degree of anatomical anterior or posterior flexion of the uterus (uterocervical angle) at the intersection of both lines using a protractor, provided that straight lines are drawn from the middle of the cervical canal and the middle of the endometrial canal in cases where the intrauterine device is found to have dislocated and and cases with no dislocation. Investigators will also measure uterus size, uterine width, cervical canal length, endometrial canal length, endometrial canal width and compare the results in both groups.